Medicare Enrolled
Dr. Sanober Kable, MD
Critical Care Medicine · Denison, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kable from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kable?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kable
Dr. Sanober Kable is a critical care medicine specialist in Denison, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kable performed 40,955 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kable received a total of $239,350 from 58 pharmaceutical and/or device companies across 1728 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kable is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 0% volume in TX
$239,350 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗40,955
Medicare services
Top 0% in TX for critical care medicine
Not available
Unique patients (not deduplicated)
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 17,117 | $30 | $40 |
| Injection, mepolizumab, 1 mg | 14,270 | $23 | $60 |
| Injection, benralizumab, 1 mg | 1,740 | $132 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,327 | $93 | $210 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
974 | $11 | $79 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
937 | $3 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
690 | $65 | $150 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
660 | $41 | $149 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
631 | $39 | $150 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
549 | $24 | $100 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
449 | $28 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
284 | $59 | $140 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
221 | $20 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
201 | $123 | $320 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
140 | $78 | $210 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
130 | $4 | $30 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
89 | $14 | $600 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
85 | $95 | $889 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
82 | $94 | $700 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
68 | $95 | $270 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
64 | $90 | $240 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
46 | $52 | $384 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
42 | $0 | $35 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $92 | $205 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
32 | $125 | $1,125 |
| Bronchoscopy A procedure to examine the airways inside the lungs using a thin, flexible tube with a camera. |
25 | $8 | $479 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
24 | $73 | $1,998 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
20 | $54 | $200 |
| Right heart catheterization A procedure where a thin, flexible tube is inserted into the right side of the heart to measure pressure and oxygen levels. |
12 | $98 | $1,470 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $134 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$239,350
Total received (2018-2024)
Avg $34,193/year across 7 years
Top 1% in TX for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,728
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$52,440
2023
$38,493
2022
$26,478
2021
$32,967
2020
$27,550
2019
$21,755
2018
$39,665
Payments by company (2024)
GENZYME CORPORATION
$24,729
AstraZeneca Pharmaceuticals LP
$10,246
GlaxoSmithKline, LLC.
$9,439
JAZZ PHARMACEUTICALS INC.
$6,832
Regeneron Healthcare Solutions, Inc.
$269
Actelion Pharmaceuticals US, Inc.
$243
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
Electromed, Inc.
$146
Baxter Healthcare
$56
Tactile Systems Technology Inc
$54
Takeda Pharmaceuticals U.S.A., Inc.
$47
Insmed, Inc.
$40
Mylan Specialty L.P.
$39
Axsome Therapeutics, Inc.
$39
HARMONY BIOSCIENCES LLC
$26
Avadel CNS Pharmaceuticals, LLC
$21
Novartis Pharmaceuticals Corporation
$19
Amgen Inc.
$17
Grifols USA, LLC
$16
INOGEN, INC.
$7
Top 3 companies account for 84.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$81,981
AstraZeneca Pharmaceuticals LP
$55,022
GENZYME CORPORATION
$30,689
Sunovion Pharmaceuticals Inc.
$22,327
JAZZ PHARMACEUTICALS INC.
$10,205
United Therapeutics Corporation
$9,447
Bayer HealthCare Pharmaceuticals Inc.
$9,071
Intuitive Surgical, Inc.
$4,840
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,901
Mylan Specialty L.P.
$1,371
Actelion Pharmaceuticals US, Inc.
$1,364
Boston Scientific Corporation
$1,271
ZOLL Respicardia, Inc.
$1,189
Takeda Pharmaceuticals U.S.A., Inc.
$940
Electromed, Inc.
$912
Regeneron Healthcare Solutions, Inc.
$731
Genentech USA, Inc.
$641
Bayer Healthcare Pharmaceuticals Inc.
$612
Grifols USA, LLC
$568
Novartis Pharmaceuticals Corporation
$411
Insmed, Inc.
$365
Pulmonx Corporation
$329
Ethicon Inc.
$256
Jazz Pharmaceuticals Inc.
$254
Philips Electronics North America Corporation
$240
Mallinckrodt LLC
$227
Amgen Inc.
$214
Baxter Healthcare
$214
Janssen Pharmaceuticals, Inc
$192
Advanced Respiratory, Inc
$173
Veran Medical Technologies, Inc.
$158
Tactile Systems Technology Inc
$145
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$98
Axsome Therapeutics, Inc.
$93
ADVANCED RESPIRATORY, INC
$87
Gilead Sciences, Inc.
$81
Harmony Biosciences LLC
$74
HARMONY BIOSCIENCES LLC
$66
CSL Behring
$64
PFIZER INC.
$61
Eisai Inc.
$47
Mallinckrodt Hospital Products Inc.
$45
Shire North American Group Inc
$43
Mallinckrodt Enterprises LLC
$41
Exeltis, USA Inc.
$39
Circassia Pharmaceuticals Inc
$33
Vapotherm Inc
$32
Merck Sharp & Dohme LLC
$26
Supernus Pharmaceuticals, Inc.
$22
Avadel CNS Pharmaceuticals, LLC
$21
Covis Pharma GmBH
$19
Cumberland Pharmaceuticals, Inc.
$19
Merck Sharp & Dohme Corporation
$16
Inogen, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$14
Pernix Therapeutics Holdings, Inc.
$14
Currax Pharmaceuticals LLC
$11
INOGEN, INC.
$7
Top 3 companies account for 70.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACQUIRE · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Belviq · CHANTIX · CHARTIS CATHETER · CONTRAVE · CUVITRU · DUPIXENT · Da Vinci Surgical System · Dayvigo · ELIQUIS · Esbriet · FARXIGA · FASENRA · Flexitouch Plus · GENERAL PULMONARY · GLASSIA · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · InogenOne · LONHALA MAGNAIR · LUMRYZ · Letairis · LifeVest · Monarch Platform · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · REMODULIN · Respiratoriy Care Undiv · SEEBRI NEOHALER · SILENOR · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TROKENDI XR · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · ULTRAFLEX · UPTRAVI · UTIBRON NEOHALER · Utibron · Vibativ · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xofluza · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Critical care medicines in nearby ZIP areas
3
County median income
$70,455
Nearest hospital to ZIP centroid (approximate)
TEXOMA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kable is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kable experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Kable performed 17,117 omalizumab injection (xolair) for asthma/allergy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kable receive payments from pharmaceutical companies?
Yes. Dr. Kable received a total of $239,350 from 58 companies across 1,728 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kable's costs compare to other critical care medicines in Denison?
Dr. Kable's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kable) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Denison
Browse critical care medicines in Denison ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in TX
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in TX
Which TX critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology